Secondary acute lymphoblastic leukaemia following oxaliplatin for adjuvant chemotherapy in colon cancer

To the Editor A highly increased risk of myelodysplasia and acute leukaemia is well established in patients previously treated for other malignancies with alkylating agents or topoisomerase II inhi...